Pfizer’s Subsidiary Biohaven Settles for Nearly $60M Over Speaker Programs: Complaint included Significant Open Payments Under Reporting Read more
Teva Pharmaceuticals Settles for $450 Million: The DOJ’s Latest Enforcement Under the Anti-Kickback Statute and False Claims Act: Settlement Agreements Read more